Literature DB >> 12359048

Appearance of osteonectin-expressing fibroblastic cells in early rat stomach carcinogenesis and stomach tumors induced with N-methyl-N'-nitro-N-nitrosoguanidine.

Hack-Young Maeng1, Dong-Kug Choi, Motoi Takeuchi, Masami Yamamoto, Michiyo Tominaga, Tetsuya Tsukamoto, Masae Tatematsu, Takashi Ito, Yoshiyuki Sakaki, Chie Furihata.   

Abstract

The present study was designed to define molecular alterations in the initiation stage of rat stomach carcinogenesis. Groups of male Lewis rats, 6 weeks old, were given drinking water with or without N-methyl-N'-nitro-N-nitrosoguanidine (MNNG; 100 mg/liter). Total RNA was isolated from the stomach pyloric mucosa, and fluorescent differential display analysis was performed. A cDNA fragment of 125 bp encoding an extracellular matrix-associated matricellular glycoprotein, osteonectin, was identified after 14 days of MNNG exposure. A severalfold increase in expression was observed after 14 and 27 days of MNNG exposure, as determined by northern blot and RT-PCR. Immunohistochemistry revealed that osteonectin-mAb-stained fibroblastic cells appeared in interstitial tissue of pyloric mucosa. Additionally the gene expression of other extracellular matrix proteins, viz., collagen type III, fibronectin, osteopontin, proteoglycan NG2, laminin gamma1 and S-laminin, was also markedly increased, as determined by competitive RT-PCR after 14 days of MNNG exposure. The gene expression of osteonectin and the six other extracellular matrix proteins was elevated in twelve stomach adenocarcinomas and adenomas induced by MNNG in Lewis and WKY rats. Osteonectin-mAb-stained fibroblastic cells were evident in interstitial tissue of stomach tumor. These results suggest that osteonectin-expressing fibroblastic cells appear in the interstitial tissue of pyloric mucosa from the early initiation stage of rat stomach chemical carcinogenesis, and that this phenomenon probably plays a role in cancer development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359048      PMCID: PMC5927132          DOI: 10.1111/j.1349-7006.2002.tb02471.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  25 in total

Review 1.  Molecular epidemiology, pathogenesis and prevention of gastric cancer.

Authors:  C T Stadtländer; J W Waterbor
Journal:  Carcinogenesis       Date:  1999-12       Impact factor: 4.944

2.  Co-expression of osteopontin and CD44v9 in gastric cancer.

Authors:  T Ue; H Yokozaki; Y Kitadai; S Yamamoto; W Yasui; T Ishikawa; E Tahara
Journal:  Int J Cancer       Date:  1998-04-17       Impact factor: 7.396

3.  Extracellular matrix expression in metastasizing and nonmetastasizing adenocarcinomas of the lung.

Authors:  M R Clarke; R J Landreneau; S D Finkelstein; T T Wu; P Ohori; S A Yousem
Journal:  Hum Pathol       Date:  1997-01       Impact factor: 3.466

4.  Differential expression of osteonectin/SPARC during human prostate cancer progression.

Authors:  R Thomas; L D True; J A Bassuk; P H Lange; R L Vessella
Journal:  Clin Cancer Res       Date:  2000-03       Impact factor: 12.531

5.  Differentially expressed MHC class II-associated invariant chain in rat stomach pyloric mucosa with N-methyl-N-nitro-nitrosoguanidine exposure.

Authors:  C Furihata; M Oka; M Yamamoto; T Ito; M Ichinose; K Miki; M Tatematsu; Y Sakaki; K Reske
Journal:  Cancer Res       Date:  1997-04-15       Impact factor: 12.701

Review 6.  The biology of SPARC, a protein that modulates cell-matrix interactions.

Authors:  T F Lane; E H Sage
Journal:  FASEB J       Date:  1994-02       Impact factor: 5.191

7.  Osteonectin-expressing cells in human stomach cancer and their possible clinical significance.

Authors:  Hack-Young Maeng; Seok Bean Song; Dong-Kug Choi; Kyoon Eon Kim; Hyun Young Jeong; Yoshiyuki Sakaki; Chie Furihata
Journal:  Cancer Lett       Date:  2002-10-08       Impact factor: 8.679

8.  Immunohistochemical demonstration of pyloric gland-type cells with low-pepsinogen isozyme 1 in preneoplastic and neoplastic tissues of rat stomachs treated with N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  M Tatematsu; C Furihata; T Katsuyama; Y Mera; T Inoue; T Matsushima; N Ito
Journal:  J Natl Cancer Inst       Date:  1987-04       Impact factor: 13.506

9.  Fluorescent differential display analysis of gene expression in apoptotic neuroblastoma cells.

Authors:  D K Choi; T Ito; Y Mitsui; Y Sakaki
Journal:  Gene       Date:  1998-11-26       Impact factor: 3.688

10.  Involvement of dendritic cell response to resistance of stomach carcinogenesis caused by N-methyl-N'-nitro-N-nitrosoguanidine in rats.

Authors:  M Oka; C Furihata; K Kitoh; M Yamamoto; M Tatematsu; M Ichinose; K Miki; T Ito; Y Sakaki; K Reske
Journal:  Cancer Res       Date:  1998-09-15       Impact factor: 12.701

View more
  4 in total

1.  Downregulation of SPARC expression decreases gastric cancer cellular invasion and survival.

Authors:  Jie Yin; Guowei Chen; Yucun Liu; Si Liu; Pengyuan Wang; Yuanlian Wan; Xin Wang; Jing Zhu; Hongqiao Gao
Journal:  J Exp Clin Cancer Res       Date:  2010-06-02

2.  Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance.

Authors:  C-S Wang; K-H Lin; S-L Chen; Y-F Chan; S Hsueh
Journal:  Br J Cancer       Date:  2004-11-29       Impact factor: 7.640

3.  Human gastric cancer risk screening: From rat pepsinogen studies to the ABC method.

Authors:  Chie Furihata
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2021       Impact factor: 3.493

4.  SPARC: a matricellular regulator of tumorigenesis.

Authors:  Shanna A Arnold; Rolf A Brekken
Journal:  J Cell Commun Signal       Date:  2009-10-07       Impact factor: 5.782

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.